UK-based scientists have developed a new three-in-one blood test able to identify the patients with advanced prostate cancer most likely to benefit from PARP inhibitors, with the potential to ‘transform’ treatment of the disease. Read more read more →

Researchers at Moffitt Cancer Center have revealed the mechanism that explains the transformation process of prostate cells into castration-resistant cancer cells. They’ve also identified a new drug candidate that targets this specific mechanism, preventing the growth and proliferation of these aggressive and deadly cancer cells. Read more read more →

The Fifth Annual Prostate Health Education Symposium is being presented by the Prostate Health Education Network, a nonprofit advocacy and education group founded, in 2003, by Boston area businessman Thomas A. Farrington. Read more read more →

I recently had an awkward conversation with my doctor. I was getting a routine physical, and he recommended that I get a PSA test for prostate cancer. I’m 63. Read more read more →

PROSTATE cancer treatment has taken a giant leap forward following new results from a drugs trial which could double life expectancy for men affected by the disease. Read more read more →

If caught early, prostate cancer is one of the most treatable cancers with high survival rates. However, research has shown that black men are twice as likely to die from prostate cancer than white men. Read more   read more →

BOSTON—Researchers have reported findings from a study showing that a new way to measure serum PSA is more accurate than currently used assays in discriminating the presence or absence of prostate cancer (PCa) and high-grade from low-grade PCa. Read more  read more →

Howard Wolinsky, a journalist based in the Chicago area, was diagnosed with early prostate cancer in 2010. He describes his journey from diagnosis to the decision to chose active surveillance. In this installment he shares his experience seeking a support group. Read more  read more →

In this patient education video, Dr. Jorge A. Garcia provides an introductory explanation of prostate cancer, its treatment options, and advances in treatment and research. Read more  read more →

Boston, MA (UroToday.com) The relationship between diabetes mellitus and metabolic syndrome with prostate cancer continues to be of debate. Recent literature sites metformin (an anti-hyperglycemic medication) to be able to modify gene expression in prostate cancer cells, with its attendant impact on lowering prostate-specific antigen (PSA) levels in the blood. Read more  read more →